Dasantafil
569351-91-3 CAS NO
405214-79-1 (racemate)
UNII-48P711MI2G, SCH 446132, D03657,
Molecular Formula: C22H28BrN5O5
Molecular Weight: 522.39222
Merck & Co. (Originator) IN PHASE 2
THERAPEUTIC CLAIM treatment of erectile dysfunction (phosphodiesterase (PDE) 5 isoenzyme inhibitor)
read all at
ALL ABOUT DRUGS
CLICK BELOW
http://www.allfordrugs.com/2014/01/29/dasantafil-for-treatment-of-erectile-dysfunction/
Filed under: Phase2 drugs, Uncategorized Tagged: DASANTAFIL, erectile dysfunction, phase 2
